Testing an Exercise Intervention to Improve Aerobic Conditioning and Autonomic Function after an Implantable Cardioverter Defibrillator (ICD)

被引：9

作者：

Dougherty, Cynthia M. ^{[1
]}

Glenny, Robb W. ^{[2
]}

Kudenchuk, Peter J. ^{[3
]}

Malinick, Todd E. ^{[1
]}

Flo, Gayle L. ^{[1
]}

机构：

[1] Univ Washington, Sch Nursing, Seattle, WA 98195 USA

[2] Univ Washington, Div Pulm & Crit Care, Dept Physiol & Med Biophys, Sch Med, Seattle, WA 98195 USA

[3] Univ Washington, Div Cardiol, Arrhythmia Serv, Sch Med,Dept Med, Seattle, WA 98195 USA

来源：

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2010年 / 33卷 / 08期

基金：

美国国家卫生研究院;

关键词：

exercise; aerobic conditioning; self-efficacy; implantable cardioverter defibrillator (ICD); intervention; walking; ICD shocks; HEART-RATE-VARIABILITY; ACUTE MYOCARDIAL-INFARCTION; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; FAILURE; MORTALITY; FITNESS; REHABILITATION; RELIABILITY; MODULATION;

D O I：

10.1111/j.1540-8159.2010.02728.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Methods: The exercise intervention has two phases that include an 8-week aerobic conditioning component followed by a 16-week exercise maintenance component. The aerobic exercise intervention is expected to have significant impact on cardiopulmonary function, ventricular arrhythmias, cardiac autonomic function, and self-efficacy in persons who have an ICD. The exercise intervention is currently being tested using a randomized clinical trial format, the results of which will be available in 2012. Conclusion: The exercise after ICD trial is one of the first clinical trials to test the effects of aerobic exercise on cardiopulmonary outcomes after receiving an ICD for primary or secondary prevention of sudden cardiac arrest. (PACE 2010; 973-980).

引用

下载

页码：973 / 980

页数：8

共 50 条

[41] HIGHER MORTALITY RISK AMONG PATIENTS WITH DELAYED FOLLOW-UP AFTER IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) PROCEDURES
Laksman, Z.
Krahn, A.
Dorian, P.
Simpson, C.
Healey, J.
Crystal, E.
Khaykin, Y.
Chen, Z.
Lee, D.
CANADIAN JOURNAL OF CARDIOLOGY, 2013, 29 (10) : S105 - S105
[42] Implantable cardioverter defibrillator (ICD) treatment and cardiac death after percutaneous transluminal septal myocardial ablation (PTSMA) in hypertrophy
Jensen, Morten
Jensen, Morten K.
Havndrup, Ole
Helqvist, Steffen
Kelbaek, Henning
Jorgensen, Erik
Hassager, Christian
Kober, Lars
Bundgaard, Henning
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 (06) : II - II
[43] Predictors of Short-Term Complications After Implantable Cardioverter-Defibrillator Replacement Results From the Ontario ICD Database
Krahn, Andrew D.
Lee, Douglas S.
Birnie, David
Healey, Jeffrey S.
Crystal, Eugene
Dorian, Paul
Simpson, Christopher S.
Khaykin, Yaariv
Cameron, Douglas
Janmohamed, Amir
Yee, Raymond
Austin, Peter C.
Chen, Zhongliang
Hardy, Judy
Tu, Jack V.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2011, 4 (02): : 136 - U53
[44] CAUSES AND PREDICTORS OF 90-DAY READMISSION AFTER IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD)- AN ANALYSIS OF THENATIONWIDE READMISSIONS DATABASE (NRD)
Murthi, Mukunthan
Velagapudi, Sujitha
Sharma, Bharosa
Shrestha, Prajwal
Shaka, Hafeez
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 442 - 442
[45] Defibrillation Threshold Testing During Implantable Cardioverter-Defibrillator Implantation is Associated With Temporal Impairment of Cardiac Function
Toh, Norihisa
Nishii, Nobuhiro
Morita, Hiroshi
Taniguchi, Manabu
Nagase, Satoshi
Nakamura, Kazufumi
Kusano, Kengo F.
Ito, Hiroshi
CIRCULATION, 2009, 120 (18) : S638 - S638
[46] Percutaneous coronary intervention and the need for an implantable cardioverter-defibrillator after out-of-hospital cardiac arrest
Auer, Johann
Lamm, Gudrun
EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2022, 11 (07) : 532 - 534
[47] Electromagnetic Interference from Left Ventricular Assist Device (LVAD) Inhibiting the Pacing Function of an Implantable Cardioverter-Defibrillator (ICD) Device
Erqou, Sebhat
Kormos, Robert L.
Wang, Norman C.
McNamara, Dennis M.
Bazaz, Raveen
CASE REPORTS IN CARDIOLOGY, 2018, 2018
[48] Isolated left ventricular diastolic dysfunction immediately after defibrillation threshold testing in patients with implantable cardioverter defibrillator
Horigome, Miki
Koyama, Jun
Horigome, Mitsuaki
Aizawa, Kazunori
Kasai, Hiroki
Tomita, Takeshi
Kumazaki, Setsuo
Tsutsui, Hiroshi
Yazaki, Yoshikazu
Kinoshita, Osamu
Ikeda, Uichi
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (09) : 144A - 144A
[49] Stereotactic arrhythmia radioablation: A multicenter pre-post intervention safety evaluation of the implantable cardioverter-defibrillator function
van der Ree, Martijn H.
Hoeksema, Wiert F.
Luca, Adrian
Visser, Jorrit
Balgobind, Brian, V
Zumbrink, Michiel
Spier, Raymond
Herrera-Siklody, Claudia
Lee, Justin
Bates, Matthew
Daniel, Jim
Peedell, Clive
Boda-Heggemann, Judit
Rudic, Boris
Merten, Roland
Dieleman, Edith M.
Rinaldi, Cristopher A.
Ahmad, Shahreen
Whitaker, John
Bhagirath, Pranav
Hatton, Matthew Q.
Riley, Stephen
Grehn, Melanie
Schiappacasse, Luis
Blanck, Oliver
Hohmann, Stephan
Pruvot, Etienne
Postema, Pieter G.
RADIOTHERAPY AND ONCOLOGY, 2023, 189
[50] Developing a risk score to predict mortality in the first year after implantable cardioverter defibrillator implantation: Data from the Israeli ICD Registry
Nevzorov, Roman
Goldenberg, Ilan
Konstantino, Yuval
Golovchiner, Gregory
Strasberg, Boris
Souleiman, Mahmoud
Khalameizer, Vladimir
Ben-Zvi, Shlomit
Sela, Ron
Rosenheck, Shimon
Freedberg, Nahum A.
Geist, Michael
Cohen, Michal Einhorn
Cohen, Tal
Shlomo, Nir
Gabrielov-Yusim, Natalie
Geva, Diklah
Glikson, Michael
Haim, Moti
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2018, 29 (11) : 1540 - 1547

← 1 2 3 4 5 →